skip to main content
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Resultados 1 2 next page
Refinado por: Nome da Publicação: Cancer remover assunto: Medical Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome‐related burkitt lymphoma/leukemia
Material Type:
Artigo
Adicionar ao Meu Espaço

Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome‐related burkitt lymphoma/leukemia

Cortes, Jorge ; Thomas, Deborah ; Rios, Adan ; Koller, Charles ; O'Brien, Susan ; Jeha, Sima ; Faderl, Stefan ; Kantarjian, Hagop

Cancer, 2002-03, Vol.94 (5), p.1492-1499 [Periódico revisado por pares]

New York: John Wiley & Sons, Inc

Texto completo disponível

2
New agents in acute myeloid leukemia and other myeloid disorders
Material Type:
Artigo
Adicionar ao Meu Espaço

New agents in acute myeloid leukemia and other myeloid disorders

Ravandi, Farhad ; Kantarjian, Hagop ; Giles, Francis ; Cortes, Jorge

Cancer, 2004-02, Vol.100 (3), p.441-454 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

3
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: Final results of cancer and leukemia group B study 9251
Material Type:
Artigo
Adicionar ao Meu Espaço

Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: Final results of cancer and leukemia group B study 9251

RIZZIERI, David A ; JOHNSON, Jeffrey L ; CANELLOS, George P ; LARSON, Richard A ; NIEDZWIECKI, Donna ; LEE, Edward J ; VARDIMAN, James W ; POWELL, Bayard L ; BARCOS, Maurice ; BLOOMFIELD, Clara D ; SCHIFFER, Charles A ; PETERSON, Bruce A

Cancer, 2004-04, Vol.100 (7), p.1438-1448 [Periódico revisado por pares]

New York, NY: Wiley-Liss

Texto completo disponível

4
Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma
Material Type:
Artigo
Adicionar ao Meu Espaço

Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma

Jimeno, Antonio ; Amador, María Luz ; González‐Cortijo, Lucía ; Tornamira, María Victoria ; Ropero, Santiago ; Valentín, Vicente ; Hornedo, Javier ; Cortés‐Funes, Hernán ; Colomer, Ramón

Cancer, 2004-05, Vol.100 (9), p.1833-1842 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

5
Low‐dose weekly paclitaxel for recurrent or refractory aggressive non‐Hodgkin lymphoma
Material Type:
Artigo
Adicionar ao Meu Espaço

Low‐dose weekly paclitaxel for recurrent or refractory aggressive non‐Hodgkin lymphoma

Rizzieri, David A. ; Sand, Gregory J. ; McGaughey, Dean ; Moore, Joseph O. ; DeCastro, Carlos ; Chao, Nelson J. ; Vredenburgh, James J. ; Gasparetto, Cristina ; Long, Gwynn D. ; Anderson, Elizabeth ; Foster, Tracy ; Toaso, Bonnie ; Adams, Donna ; Niedzwiecki, Donna ; Gockerman, Jon P.

Cancer, 2004-06, Vol.100 (11), p.2408-2414 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

6
Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia
Material Type:
Artigo
Adicionar ao Meu Espaço

Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

Thomas, Deborah A. ; Faderl, Stefan ; O'Brien, Susan ; Bueso‐Ramos, Carlos ; Cortes, Jorge ; Garcia‐Manero, Guillermo ; Giles, Francis J. ; Verstovsek, Srdan ; Wierda, William G. ; Pierce, Sherry A. ; Shan, Jianqin ; Brandt, Mark ; Hagemeister, Fredrick B. ; Keating, Michael J. ; Cabanillas, Fernando ; Kantarjian, Hagop

Cancer, 2006-04, Vol.106 (7), p.1569-1580 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

7
Recommendations for the use of Yttrium‐90 ibritumomab tiuxetan in malignant lymphoma
Material Type:
Artigo
Adicionar ao Meu Espaço

Recommendations for the use of Yttrium‐90 ibritumomab tiuxetan in malignant lymphoma

Weigert, Oliver ; Illidge, Tim ; Hiddemann, Wolfgang ; Dreyling, Martin

Cancer, 2006-08, Vol.107 (4), p.686-695 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

8
Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation
Material Type:
Artigo
Adicionar ao Meu Espaço

Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

Sorror, Mohamed ; Storer, Barry ; Sandmaier, Brenda M. ; Maloney, David G. ; Chauncey, Thomas R. ; Langston, Amelia ; Maziarz, Richard T. ; Pulsipher, Michael ; McSweeney, Peter A. ; Storb, Rainer

Cancer, 2008-05, Vol.112 (9), p.1992-2001 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

9
Targeting mTOR in renal cell carcinoma
Material Type:
Artigo
Adicionar ao Meu Espaço

Targeting mTOR in renal cell carcinoma

Hudes, Gary R.

Cancer, 2009-05, Vol.115 (S10), p.2313-2320 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

10
A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer

Amato, Robert J. ; Jac, Jaroslaw ; Giessinger, Sarah ; Saxena, Somyata ; Willis, James P.

Cancer, 2009-06, Vol.115 (11), p.2438-2446 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Resultados 1 2 next page

Buscando em bases de dados remotas. Favor aguardar.